Agenda for 13th Annual Biomarkers Congress

Oxford Global are pleased to share with you the final agenda for our highly anticipated 13th Annual Biomarkers Congress, 15 - 16 February 2018, Manchester, UK.

 

Across two days, the scientific congress will bring together over 300 delegates to attend interactive think tank breakfast sessions, workshop and presentations, covering the key solutions to biomarker discovery and development challenges.

 

Alongside innovative case studies on biomarker technologies for Immuno-therapy, Neuroscience & Oncology as well as Cardiovascular and COPD disease areas, there are dedicated streams on the Assay Validation and Translational Development; Biomarker: Clinical Development & Clinical Trials; Diagnostics and Precision Medicine; as well as Genomic Driven Biomarker Research.

 

What more?

Get inspired by our unmissable presentations from our keynote speakers:

 

♦ Roy Baynes, Senior Vice President and Head Global Clinical Development, Chief Medical

Officer, MSD

♦ Rose Maciewicz, Vice President, Respiratory & Inflammation iMed, AstraZeneca

♦ Mark Fidock, Vice President & Head of Personalised Healthcare and Biomarkers

Laboratories, AstraZeneca

♦ Chris Chamberlain, Vice President and Head of Experimental Medicine and Diagnostics,

UCB

 

VIEW THE AGENDA HERE>>

 

To receive further information regarding the Congress, the registration fees and what

discounts we have available please contact a.fernandez@oxfordglobal.co.uk

 

Notes :

1. Angela Fernandez Saez, a.fernandez@oxfordglobal.co.uk +44 1865 248455

2. Oxford Global Conferences, +44 1865 248455. www.oxfordglobal.co.uk

3. Godstow Court, 5 West Way, Oxford OX2, Oxford, UKPart 1st Floor Godstow Court, Minns Business Park,

Botley, Oxford, OX2 0JB